However, the largest study comparing 33 MDS and 74 AML patients showed that MDS patients were generally older, had lower peripheral blood blast and total white blood cell counts, higher platelet counts, and lower frequency of FLT3 mutations. This evidence concerns the gene FLT3 and acute myeloid leukemia.